Tuberculosis (TB) treatment challenges in TB-diabetes comorbid patients: a systematic review and meta-analysis.
Mahnoor KhattakAnees Ur RehmanTuba MuqaddasRabia HussainMuhammad Fawad RasoolZikria SaleemMesfer Safar AlmalkiSamar Adel AlturkistaniShuruq Zuhair FirashOseid Mohammed AlzahraniAmmar Abdulraheem BahauddinSafa Almarzooky AbuhussainMuath Fahmi NajjarHossameldeen Mahmoud Ali ElsabaaAbdul HaseebPublished in: Annals of medicine (2024)
A negative impact of DM was found on recurrence and extended treatment duration in TB patients treated with DOTS therapy. DM type 2 is responsible for the TB treatment prolongation and TB recurrence rates. By implementing effective management strategies and advancing research, the challenges can be mitigated, arising due to the complex interaction between DM and TB.
Keyphrases
- mycobacterium tuberculosis
- type diabetes
- end stage renal disease
- cardiovascular disease
- chronic kidney disease
- ejection fraction
- stem cells
- newly diagnosed
- mesenchymal stem cells
- emergency department
- skeletal muscle
- pulmonary tuberculosis
- peritoneal dialysis
- drug induced
- hepatitis c virus
- mass spectrometry
- high resolution
- antiretroviral therapy
- patient reported